Compounds > adenosine diphosphate
Page last updated: 2024-08-17

adenosine diphosphate and Bone Loss, Osteoclastic

adenosine diphosphate has been researched along with Bone Loss, Osteoclastic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luckprom, P; Pavasant, P; Wongkhantee, S; Yongchaitrakul, T1
Collins, L; Conley, PB; Craft, CS; Deng, H; Eagleton, MC; Floyd, DH; Grabowska, D; Heller, E; Hirbe, AC; Hughes, A; Hurchla, MA; Novack, DV; Piwnica-Worms, D; Rogers, M; Schneider, JG; Steinberg, TH; Su, X; Townsley, S; Uluckan, O; Weilbaecher, KN; Wu, K; Xiang, J; Zou, W1
Brosnan, JT; Brosnan, ME1
Arnett, TR; Burnstock, G; Hoebertz, A; Meghji, S1

Reviews

1 review(s) available for adenosine diphosphate and Bone Loss, Osteoclastic

ArticleYear
Dietary protein, metabolic acidosis, and calcium balance.
    Advances in nutritional research, 1982, Volume: 4

    Topics: Acid-Base Equilibrium; Acidosis; Adenosine Diphosphate; Adenosine Triphosphate; Ammonia; Ammonium Chloride; Anions; Bone Development; Bone Resorption; Buffers; Calcitriol; Calcium; Cations; Dietary Proteins; Humans; Hydrogen-Ion Concentration; Kidney; Osteoporosis; Parathyroid Hormone; Phosphoproteins

1982

Other Studies

3 other study(ies) available for adenosine diphosphate and Bone Loss, Osteoclastic

ArticleYear
Adenosine triphosphate stimulates RANKL expression through P2Y1 receptor-cyclo-oxygenase-dependent pathway in human periodontal ligament cells.
    Journal of periodontal research, 2010, Volume: 45, Issue:3

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Biomechanical Phenomena; Bone Remodeling; Bone Resorption; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Enzyme Inhibitors; Estrenes; Humans; Indomethacin; Isoquinolines; NF-kappa B; Periodontal Ligament; Phosphodiesterase Inhibitors; Purinergic P2 Receptor Antagonists; Pyrrolidines; Pyrrolidinones; RANK Ligand; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; RNA, Small Interfering; Sulfonamides; Thiocarbamates; Type C Phospholipases

2010
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
    The Journal of clinical investigation, 2012, Volume: 122, Issue:10

    Topics: Adenosine Diphosphate; Animals; Arthritis, Experimental; Bone Neoplasms; Bone Remodeling; Bone Resorption; Carcinoma; Cell Adhesion; Cells, Cultured; Clopidogrel; Enzyme Activation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoclasts; Osteoporosis; Ovariectomy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; rap1 GTP-Binding Proteins; Receptors, Purinergic P2Y12; Specific Pathogen-Free Organisms; Ticlopidine

2012
Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y(1) receptor on bone cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:7

    Topics: Adenosine Diphosphate; Animals; Bone and Bones; Bone Resorption; Calcium; Cells, Cultured; Chondrocytes; Immunohistochemistry; In Situ Hybridization; Mice; Osteoblasts; Osteoclasts; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Signal Transduction; Thionucleotides

2001